文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

使用基于贝叶斯网络的决策支持工具估计长新冠风险

Estimating risk of long COVID using a Bayesian network-based decision support tool.
PubMed 文献 · Vaccine · 2025-12-18

研究开发贝叶斯网络模型,基于人口学、合并症和可改变因素(疫苗接种史、既往感染次数、急性期药物治疗)估计长新冠概率,并构建交互式网络决策支持工具。接种疫苗、急性感染三天内接受药物治疗和避免重复感染是最大的可改变影响因素,在建模情景下可将风险降低最多63%。

要点

  • 接种疫苗、急性感染三天内用药和避免重复感染是长新冠最大的可改变影响因素。
  • 在建模情景下,上述可改变因素可将长新冠风险降低最多63%。
  • 交互式网络决策支持工具可计算个体在不同可改变因素情景下的长新冠概率。

核心结论

  • 决策支持工具可供个体或与临床医生共同用于疫苗接种、急性感染期早期药物治疗和继续采取防护行为(如戴口罩和保持社交距离)的共享决策。
  • 该模型还可生成人群水平的结局估计,以协助公共卫生决策者制定更明智的公共卫生政策。

研究设计与样本

  • 开发贝叶斯网络模型,数据来源于已发表研究和政府报告。
  • 模型根据人口学(性别、年龄)、合并症和可改变因素(疫苗接种史、既往SARS-CoV-2感染次数、急性感染期药物治疗)估计长新冠概率。

主要发现

  • 接种疫苗、急性感染三天内接受药物治疗和避免重复感染是长新冠最大的可改变影响因素,在建模情景下可将风险降低最多63%。
  • 交互式网络决策支持工具可让个体在不同可改变因素情景下计算个人化的长新冠概率。
  • 模型还可估计急性感染期住院、ICU入住和死亡的概率,以及特定系统(心血管、胃肠、肌肉骨骼、肺、神经、肾、代谢、凝血、疲劳和心理健康)相关持续症状的风险。

临床怎么用

  • 决策支持工具可供个体或与临床医生共同用于疫苗接种、急性感染期早期药物治疗和继续采取防护行为(如戴口罩和保持社交距离)的共享决策。
  • 模型可生成人群水平结局估计,以协助公共卫生决策者制定更明智的公共卫生政策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Long COVID causes substantial health burden globally, affecting over 30 % of adults who have ever had symptomatic COVID-19. Individuals at continued risk of long COVID need better and more accessible information to make choices about vaccines and treatments. OBJECTIVE: To quantify modifiable risk factors for having long COVID six months post-infection, and develop a decision support tool for managing the risk factors. DESIGN, SETTING, AND PARTICIPANTS: A Bayesian network (BN) model was developed to estimate the probability of long COVID depending on demographics (sex, age), comorbidities, and modifiable factors (vaccination history, number of previous SARS-CoV-2 infections, and drug treatments during acute infection). Data were sourced from published studies and government reports. MAIN OUTCOME(S) AND MEASURE(S): Outcome measures include probability of hospitalisation, ICU admission, and dying from COVID-19 during the acute infection under different scenarios of demographics, comorbidities, vaccine coverage and effectiveness. The BN also estimates the risk of developing long COVID depending on modifiable risk factors, and persistent symptoms related to specific systems (cardiovascular, gastrointestinal, musculoskeletal, pulmonary, neurological, renal, metabolic, coagulation, fatigue, and mental health). RESULTS: Vaccination, receiving drug treatment within three days of acute infection, and avoiding repeated infections are the greatest modifiable influences of long COVID development, decreasing risk by up to 63 % under modelled scenarios. The interactive user-friendly web-based decision support tool (https://corical.immunisationcoalition.org.au/longcovid) enables easy access to model outputs, and allows individuals to calculate their personalised probability of long COVID under different scenarios of modifiable risk factors. CONCLUSIONS AND RELEVANCE: The decision-support tool can be used by individuals or in conjunction with clinicians for shared decision-making on vaccination, pursuing early drug treatment during acute infection, and continuing protective behaviors such as masking and social distancing. The model can also generate population-level estimates of outcomes to assist public health decision-makers to design better-informed public health policies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sinclair JE, Mayfield HJ, Lu H, et al. Estimating risk of long COVID using a Bayesian network-based decision support tool. Vaccine. 2025. PMID: 41418608. doi:10.1016/j.vaccine.2025.128127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。